New study checks if vyleesi enters breast milk
NCT ID NCT06867835
First seen Jan 21, 2026 · Last updated May 05, 2026 · Updated 17 times
Summary
This completed study looked at whether the drug Vyleesi (bremelanotide) passes into breast milk. Ten healthy, breastfeeding women received one dose, and researchers measured drug levels in their milk and blood over 24 hours. The goal was to understand how much drug might reach a nursing infant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LACTATING MOTHER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Excellence Research Group LLC
Doral, Florida, 33178, United States
Conditions
Explore the condition pages connected to this study.